Download (1.19 MB) - Australian Council on Healthcare Standards

Medi Medication Safety, v3
Reporting of adverse drug reactions to the Therapeutic Goods Administration
(TGA)
CI 1.1: Adverse drug reactions reported to OPC, TGA (N)
Rationale
Reporting of adverse drug reactions to an external body may be beneficial for the future
management and safety of patients.
Numerator
Denominator
Total number of adverse drug reactions, which were reported to ACSOM, OMSM
Total number of non same-day separations
Year
Dimensions of care: Accessibility Appropriateness Continuity
Effectiveness Quality Improvement and Risk Safety
Desirable level: Low High Not specified
Type of Indicator: Process Outcome Structure
No.
HCOs
Total
numerator
Total
denominator
Rate #
Rate#
(20)
Rate #
(80)
*Centile
Gains
*Stratum
Gains
2004 117 1,301 765,708 0.17 0.011 0.16
2005 113 1,546 824,196 0.19 0.012 0.18
2006 120 919 818,559 0.11 0.011 0.14
2007 134 1,477 1,003,158 0.15 0.008 0.15
2008 140 1,036 1,061,923 0.098 0.012 0.090
2009 153 1,129 1,158,623 0.097 0.010 0.088
2010 136 1,194 1,159,509 0.10 0.006 0.070
2011 97 1,032 893,193 0.12 0.007 0.10
#per 100 separations *Gains are not calculated when the desirable level is not specified.
In 2011 there were 151 submissions from 97 HCOs. The annual rate was 0.12 per 100
separations.
*Outlier
Gains
Trends
The fitted rate decreased from 0.17 to 0.093, a change of 0.074 per 100 separations. This trend
was also significant after allowing for the changing composition of HCOs contributing over the
period. The rate change was 0.074 per 100 separations.
Australasian Clinical Indicator Report 2004–2011 Page 1
© ACHS. This work is copyright. Requests and inquiries concerning reproduction and rights should
be addressed to pos@achs.org.au